4-methoxyamphetamine has been researched along with Acute Promyelocytic Leukemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, X; Li, L; Sun, J; Xie, M; Xie, W; Yang, X; Ye, X; Zheng, Y; Zhu, J; Zhu, L; Zhu, M | 1 |
| Aimo, A; Aquaro, GD; Barison, A; Di Paolo, M; Emdin, M; Roas, L | 1 |
| Liu, H; Qien, X; Wang, X; Wu, X; Yang, Z; Yao, H; Ying, J | 1 |
3 other study(ies) available for 4-methoxyamphetamine and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
Factors Affecting Early Death and Survival of Patients With Acute Promyelocytic Leukemia Treated With ATRA-Based Therapy Regimens.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Death; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Prognosis; Retrospective Studies; Survival Rate; Tretinoin | 2019 |
The heart after idarubicin overdose. Cardiac death in a patient with acute promyelocitic leukaemia.
Topics: Antibiotics, Antineoplastic; Death; Death, Sudden, Cardiac; Dose-Response Relationship, Drug; Drug Overdose; Fatal Outcome; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Male; Middle Aged | 2016 |
Four years' experience with the treatment of all-trans retinoic acid in acute promyelocytic leukemia.
Topics: Adolescent; Adult; Child; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Death; Female; Fibroblasts; Hemorrhage; Humans; Leukemia, Promyelocytic, Acute; Leukocyte Count; Male; Middle Aged; Retrospective Studies; Stem Cells; Time Factors; Translocation, Genetic; Tretinoin | 1993 |